ANEB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Anebulo Pharmaceuticals Inc (ANEB).


$70.80M Market Cap.

As of 09/26/2024 5:00 PM ET (MRY) • Disclaimer

ANEB Market Cap. (MRY)


ANEB Shares Outstanding (MRY)


ANEB Assets (MRY)


Total Assets

$4.07M

Total Liabilities

$260.58K

Total Investments

$0

ANEB Income (MRY)


Revenue

$0

Net Income

-$8.20M

Operating Expense

$8.31M

ANEB Cash Flow (MRY)


CF Operations

-$8.09M

CF Investing

$0

CF Financing

-$62.35K

ANEB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

-

0%

-

ANEB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$4,073,114 (-65.10%)

$11,670,151 (-25.09%)

$15,579,431 (-28.05%)

$21,653,491

Assets Current

$3,507,990 (-69.94%)

$11,670,151 (-25.09%)

$15,579,431 (-28.05%)

$21,653,491

Assets Non-Current

$565,124 (0%)

$0 (0%)

$0 (0%)

$0

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$3,812,531 (-64.04%)

$10,601,350 (-29.64%)

$15,066,900 (-29.63%)

$21,411,858

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cash & Equivalents

$3,094,200 (-72.49%)

$11,247,403 (-22.69%)

$14,548,471 (-27.21%)

$19,985,645

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$156,426 (-70.74%)

$534,545 (40.36%)

$380,828 (246.06%)

$110,048

Accumulated Retained Earnings (Deficit)

-$65,403,744 (-14.34%)

-$57,202,041 (-25.80%)

-$45,469,703 (-17.66%)

-$38,644,084

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$0

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Liabilities

$260,583 (-75.62%)

$1,068,801 (108.53%)

$512,531 (112.11%)

$241,633

Liabilities Current

$260,583 (-75.62%)

$1,068,801 (108.53%)

$512,531 (112.11%)

$241,633

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

ANEB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$4,759,818 (-23.02%)

$6,183,402 (59.79%)

$3,869,636 (187.97%)

$1,343,755

Research & Development Expense

$3,548,937 (-36.63%)

$5,600,197 (89.10%)

$2,961,538 (30.46%)

$2,269,998

Operating Expenses

$8,308,755 (-29.49%)

$11,783,599 (72.50%)

$6,831,174 (89.03%)

$3,613,753

Interest Expense

$151,230 (0%)

$0 (0%)

$0 (0%)

$11,767

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$8,201,703 (30.09%)

-$11,732,338 (-71.89%)

-$6,825,619 (77.44%)

-$30,252,554

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$8,201,703 (30.09%)

-$11,732,338 (-71.89%)

-$6,825,619 (77.44%)

-$30,252,554

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$8,208,393

Net Income Common Stock

-$8,201,703 (30.09%)

-$11,732,338 (-71.89%)

-$6,825,619 (82.25%)

-$38,460,947

Weighted Average Shares

$25,822,258 (2.98%)

$25,074,481 (7.41%)

$23,344,567 (71.49%)

$13,612,701

Weighted Average Shares Diluted

$25,822,258 (2.98%)

$25,074,481 (7.41%)

$23,344,567 (71.49%)

$13,612,701

Earning Before Interest & Taxes (EBIT)

-$8,050,473 (31.38%)

-$11,732,338 (-71.89%)

-$6,825,619 (77.43%)

-$30,240,787

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0

Operating Income

-$8,308,755 (29.49%)

-$11,783,599 (-72.50%)

-$6,831,174 (-89.03%)

-$3,613,753

ANEB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Cash Flow from Financing

-$62,354 (-100.98%)

$6,382,065 (0%)

$0 (0%)

$21,831,854

Net Cash Flow from Operations

-$8,090,849 (16.44%)

-$9,683,133 (-78.09%)

-$5,437,174 (-11.62%)

-$4,871,189

Net Cash Flow / Change in Cash & Cash Equivalents

-$8,153,203 (-146.99%)

-$3,301,068 (39.29%)

-$5,437,174 (-132.06%)

$16,960,665

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$201,286

Issuance (Purchase) of Equity Shares

$0 (0%)

$6,382,065 (0%)

$0 (0%)

$22,033,140

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$758,884 (-14.22%)

$884,723 (84.06%)

$480,661 (140.39%)

$199,947

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$0

ANEB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-138.90% (-72.12%)

-80.70% (-110.16%)

-38.40% (89.40%)

-362.10%

Return on Average Assets (ROAA)

-123.30% (-65.06%)

-74.70% (-97.62%)

-37.80% (87.87%)

-311.70%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-15337.70% (-1016.83%)

1672.90% (266.86%)

-1002.60% (76.67%)

-4298.20%

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-8.53 (-70.62%)

-5 (72.12%)

-17.93 (-644.02%)

-2.41

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

18.57 (226.82%)

5.68 (-29.48%)

8.06 (8.35%)

7.44

Debt to Equity Ratio (D/E)

0.07 (-32.67%)

0.1 (197.06%)

0.03 (209.09%)

0.01

Earnings Per Share (EPS)

-0.32 (31.91%)

-0.47 (-62.07%)

-0.29 (89.75%)

-2.83

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-0.31 (18.91%)

-0.39 (-65.67%)

-0.23 (34.92%)

-0.36

Book Value Per Share (BVPS)

0.15 (-65.01%)

0.42 (-34.42%)

0.65 (-59.00%)

1.57

Tangible Assets Book Value Per Share (TABVPS)

0.16 (-66.02%)

0.47 (-30.28%)

0.67 (-58.08%)

1.59

Enterprise Value Over EBIT (EV/EBIT)

-8 (-100.00%)

-4 (73.33%)

-15 (-200.00%)

-5

Enterprise Value Over EBITDA (EV/EBITDA)

-8.15 (-107.66%)

-3.93 (74.43%)

-15.36 (-197.96%)

-5.16

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0

Current Ratio

13.46 (23.29%)

10.92 (-64.08%)

30.4 (-66.08%)

89.61

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$8,090,849 (16.44%)

-$9,683,133 (-78.09%)

-$5,437,174 (-11.62%)

-$4,871,189

Enterprise Value (EV)

$65,650,543 (42.49%)

$46,073,255 (-56.06%)

$104,844,021 (-32.75%)

$155,902,864

Earnings Before Tax (EBT)

-$8,201,703 (30.09%)

-$11,732,338 (-71.89%)

-$6,825,619 (77.44%)

-$30,252,554

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$8,050,473 (31.38%)

-$11,732,338 (-71.89%)

-$6,825,619 (77.43%)

-$30,240,787

Invested Capital

$718,331 (211.19%)

-$646,053 (-224.62%)

$518,429 (-63.65%)

$1,426,213

Working Capital

$3,247,407 (-69.37%)

$10,601,350 (-29.64%)

$15,066,900 (-29.63%)

$21,411,858

Tangible Asset Value

$4,073,114 (-65.10%)

$11,670,151 (-25.09%)

$15,579,431 (-28.05%)

$21,653,491

Market Capitalization

$70,797,682 (17.53%)

$60,238,060 (-50.38%)

$121,391,748 (-23.75%)

$159,209,947

Average Equity

$5,904,096 (-59.41%)

$14,543,978 (-18.10%)

$17,759,038 (67.22%)

$10,620,360

Average Assets

$6,654,352 (-57.62%)

$15,701,594 (-13.12%)

$18,073,028 (46.45%)

$12,340,986

Invested Capital Average

$52,488 (107.48%)

-$701,336 (-203.02%)

$680,806 (-3.24%)

$703,567

Shares

25,933,217 (1.17%)

25,633,217 (9.80%)

23,344,567 (0.00%)

23,344,567